Erythema Protection Efficacy of Plant-Derivative Compounds in Mice Based on Narrow-Band Reflectance Spectroscopy Data
Abstract
1. Introduction
2. Materials and Methods
2.1. UVB-Induced Erythema Kinetics
2.2. Erythema Protection Efficacy of the Compounds in Mice
2.3. Statistical Analysis
3. Results
3.1. UVB-Induced Skin Erythema in Albino BALB/c Mice
3.2. Erythema Protection Efficacy of Phytochemicals
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| CPDs | Cyclobutane pyrimidine dimers |
| EGCG | Epigallocatechin gallate |
| EI | Erythema Index |
| EIp | EI of protected mice skin |
| EIu | EI of unprotected mice skin |
| EIP | Erythema Inhibition Percentage |
| EPE | Erythema Protection Efficacy |
| EPEc | Corrected EPE |
| MED | Minimum Erythema Dose |
| MEDp | MED of protected skin |
| MEDu | MED of unprotected skin |
| SPF | Sun Protection Factor |
References
- Martens, M.C.; Seebode, C.; Lehmann, J.; Emmert, S. Photocarcinogenesis and skin cancer prevention strategies: An update. Anticancer. Res. 2018, 38, 1153–1158. [Google Scholar] [CrossRef] [PubMed]
- Islami, F.; Sauer, A.G.; Miller, K.D.; Fedewa, S.A.; Minihan, A.K.; Geller, A.C.; Lichtenfeld, J.L.; Jemal, A. Cutaneous melanomas attributable to ultraviolet radiation exposure by state. Int. J. Cancer 2020, 147, 1385–1390. [Google Scholar] [CrossRef]
- Al-Sadek, T.; Yusuf, N. Ultraviolet radiation biological and medical implications. Curr. Issues Mol. Biol. 2024, 46, 1924–1942. [Google Scholar] [CrossRef] [PubMed]
- Young, A.R.; Harrison, G.I.; Chadwick, C.A.; Nikaido, O.; Ramsden, J.; Potten, C.S. The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema. J. Investig. Dermatol. 1998, 111, 982–988. [Google Scholar] [CrossRef] [PubMed]
- Osterwalder, U.; Herzog, B. Sun protection factors: World-wide confusion. Br. J. Dermatol. 2009, 161, 13–24. [Google Scholar] [CrossRef]
- Osterwalder, U.; Sohn, M.; Herzog, B. Global state of sunscreens. Photodermatol. Photoimmunol. Photomed. 2014, 30, 62–80. [Google Scholar] [CrossRef]
- Chhabra, G.; Ndiaye, M.A.; Garcia-Peterson, L.M.; Ahmad, N. Melanoma Chemoprevention: Current status and future prospects. Photochem. Photobiol. 2017, 93, 975–989. [Google Scholar] [CrossRef]
- Montes de Oca, M.K.; Pearlman, R.L.; McClees, S.F.; Strickland, R.; Afaq, F. Phytochemicals for the prevention of photocarcinogenesis. Photochem. Photobiol. 2017, 93, 956–974. [Google Scholar] [CrossRef]
- Abdlaty, R.; Hayward, J.; Farrell, T.; Fang, Q. Skin erythema and pigmentation: A review of optical assessment techniques. Photodiagn. Photodyn. Ther. 2021, 33, 102127. [Google Scholar] [CrossRef]
- Villamizar-Mantilla, D.A.; Stashenko, E.E.; Fuentes-Lorenzo, J.L. Plant compounds inhibit UV radiation-induced erythema in mice skin. Nat. Prod. Res. 2025, 1–8. [Google Scholar] [CrossRef]
- European Standard ISO24444; Cosmetics—Sun Protection Test Methods—In Vivo Determination of the Sun Protection Factor (SPF) (ISO24444:2019) (Second Edition). International Standard ISO Copyright Office: Geneva, Switzerland, 2019.
- Food and Drug Administration. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use. Final rule. Fed. Reg. 2011, 76, 35620–35665. [Google Scholar]
- Yoshimura, K.; Harii, K.; Masuda, Y.; Takahashi, M.; Aoyama, T.; Iga, T. Usefulness of a narrow-band reflectance spectrophotometer in evaluating effects of depigmenting treatment. Aesthetic Plast. Surg. 2001, 25, 129–133. [Google Scholar] [CrossRef]
- Wang, Y.Y.; Hong, C.T.; Chiu, W.T.; Fang, J.Y. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int. J. Pharm. 2001, 224, 89–104. [Google Scholar] [CrossRef] [PubMed]
- R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2013; Available online: http://www.R-project.org (accessed on 10 September 2025).
- Poon, T.S.; Kuchel, J.M.; Badruddin, A.; Halliday, G.M.; Barnetson, R.S.; Iwaki, H.; Hatao, M. Objective measurement of minimal erythema and melanogenic doses using natural and solar-simulated light. Photochem. Photobiol. 2003, 78, 331–336. [Google Scholar] [CrossRef]
- Villamizar-Mantilla, D.A.; Flórez-González, S.J.; Pedraza-Barrera, C.A.; Stashenko, E.E.; Vinardell, M.P.; Fuentes, J.L. In vitro cytotoxicity, UV-filter and antigenotoxic properties of plant compounds as sunscreen ingredients. Chem. Biodivers. 2025, 22, e01383. [Google Scholar] [CrossRef]
- Jansen, R.; Osterwalder, U.; Wang, S.Q.; Burnett, M.; Lim, H.W. Photoprotection part II. Sunscreen: Development, efficacy, and controversies. J. Am. Acad. Dermatol. 2013, 69, 867.e1–867.e14. [Google Scholar] [CrossRef]
- Valbuena, M.C.; Nova-Villanueva, J.A.; Sánchez-Vanegas, G. Minimal Erythema Dose: Correlation with Fitzpatrick skin type and concordance between methods of erythema assessment in a patient sample in Colombia. Actas Dermo-Sifiliogr. 2020, 111, 390–397. [Google Scholar] [CrossRef]
- Wan, S.; Parrish, J.A.; Jaenicke, K.F. Quantitative evaluation of ultraviolet induced erythema. Photochem. Photobiol. 1983, 37, 643–648. [Google Scholar] [CrossRef] [PubMed]
- Harrison, G.A.; Young, A.R. Ultraviolet radiation-induced erythema in human skin. Methods 2002, 28, 14–19. [Google Scholar] [CrossRef] [PubMed]
- Diffey, B.L.; Farr, P.M.; Oakley, A.M. Quantitative studies on UVA-induced erythema in human skin. Br. J. Dermatol. 1987, 117, 57–66. [Google Scholar] [CrossRef]
- Gyöngyösi, N.; Lőrincz, K.; Keszeg, A.; Haluszka, D.; Bánvölgyi, A.; Tátrai, E.; Kárpáti, S.; Wikonkál, N.M. Photosensitivity of murine skin greatly depends on the genetic background: Clinically relevant dose as a new measure to replace minimal erythema dose in mouse studies. Exp. Dermatol. 2016, 25, 519–525. [Google Scholar] [CrossRef] [PubMed]
- Hirakawa, S.; Fujii, S.; Kajiya, K.; Yano, K.; Detmar, M. Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage. Blood 2005, 105, 2392–2399. [Google Scholar] [CrossRef]
- Dornelles, S.; Goldlm, J.; Cestari, T. Determination of the minimal erythema dose and colorimetric measurements as indicators of skin sensitivity to UVB radiation. Photochem. Photobiol. 2004, 79, 540–544. [Google Scholar] [CrossRef]
- Morocho-Jácome, A.L.; Freire, T.B.; de Oliveira, A.C.; de Almeida, T.S.; Rosado, C.; Velasco, M.V.R.; Baby, A.R. In vivo SPF from multifunctional sunscreen systems developed with natural compounds—A review. J. Cosmet. Dermatol. 2021, 20, 729–737. [Google Scholar] [CrossRef]
- Katiyar, S.; Matsui, M.S.; Elmets, C.A.; Mukhtar, H. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem. Photobiol. 1999, 69, 148–153. [Google Scholar] [CrossRef]
- Saija, A.; Tomaino, A.; Trombetta, D.; De Pasquale, A.; Uccella, N.; Barbuzzi, T.; Paolino, D.; Bonina, F. In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents. Int. J. Pharm. 2000, 199, 39–47. [Google Scholar] [CrossRef] [PubMed]
- Elmets, C.A.; Singh, D.; Tubesing, K.; Matsui, M.; Katiyar, S.; Mukhtar, H. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J. Am. Acad. Dermatol. 2001, 44, 425–432. [Google Scholar] [CrossRef] [PubMed]
- Kim, J.; Hwang, J.S.; Cho, Y.K.; Han, Y.; Jeon, Y.J.; Yang, K.H. Protective effects of epigallocatechin-3-gallate on UVA and UVB-induced skin Damage. Ski. Pharmacol. Appl. Ski. Physiol. 2001, 14, 11–19. [Google Scholar] [CrossRef]
- Kitagawa, S.; Yoshii, K.; Morita, S.Y.; Teraoka, R. Efficient topical delivery of chlorogenic acid by an oil-in-water microemulsion to protect skin against UV-Induced damage. Chem. Pharm. Bull. 2011, 59, 793–796. [Google Scholar] [CrossRef]
- Choquenet, B.; Couteau, C.; Paparis, E.; Coiffard, L.J. Flavonoids and polyphenols, molecular families with sunscreen potential: Determining effectiveness with an in vitro method. Nat. Prod. Commun. 2009, 4, 227–230. [Google Scholar] [CrossRef]
- Stevanato, R.; Bertelle, M.; Fabris, S. Photoprotective characteristics of natural antioxidant polyphenols. Regul. Toxicol. Pharmacol. 2014, 69, 71–77. [Google Scholar] [CrossRef] [PubMed]
- Ácsová, A.; Hojerová, J.; Janotková, L.; Bendová, H.; Jedličková, L.; Hamranová, V.; Martiniaková, S. The real UVB photoprotective efficacy of vegetable oils: In vitro and in vivo studies. Photochem. Photobiol. Sci. 2021, 20, 139–151. [Google Scholar] [CrossRef]
- García-Forero, A.; Villamizar-Mantilla, D.A.; Núñez de Villavicencio-Martínez, L.A.; Ocazionez, R.E.; Stashenko, E.E.; Fuentes, J.L. Photoprotective and antigenotoxic effects of the flavonoids apigenin, naringenin and pinocembrin. Photochem. Photobiol. 2019, 95, 1010–1018. [Google Scholar] [CrossRef] [PubMed]
- Barrios Martínez, S.; Villamizar Mantilla, D.A.; Ocazionez, R.E.; Stashenko, E.E.; Vinardell, M.P.; Fuentes, J.L. Photoprotective and antigenotoxic effects of a mixture of Posoqueria latifolia flower extract and kaempferol against ultraviolet B radiation. Photochem. Photobiol. 2025, 101, 1454–1467. [Google Scholar] [CrossRef]
- Fuentes, J.L.; Pedraza-Barrera, C.A.; Flores-González, S.J.; Barrios-Martínez, S.X.; Sierra-Prada, L.J.; Ocazionez, R.E.; Stashenko, E.E. Flower extracts from ornamental plants as sources of sunscreen ingredients: Determination by in vitro methods of photoprotective efficacy, antigenotoxicity and safety. Molecules 2022, 27, 5525. [Google Scholar] [CrossRef]
- Park, E.S.; Na, J.I.; Kim, S.O.; Huh, C.H.; Youn, S.W.; Park, K.C. Application of a pigment measuring device–Mexameter–for the differential diagnosis of vitiligo and nevus depigmentosus. Ski. Res. Technol. 2006, 2, 298–302. [Google Scholar] [CrossRef] [PubMed]


| Radiation | Weight | Reflectance and Erythema Measurements in Mouse Skin | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Doses | Upper Back Dorsal Areas | Middle Back Dorsal Areas | Lower Back Dorsal Areas | ||||||||||
| (mJ/cm2) | (g) | t (0 h) | t (24 h) | t (48 h) | EI † | t (0 h) | t (24 h) | t (48 h) | EI † | t (0 h) | t (24 h) | t (48 h) | EI † |
| Female | |||||||||||||
| 0 | 18.3 ± 1.2 | 255 ± 0 | 267 ± 2 | 270 ± 0 | 15 ± 3 | 178 ± 2 | 180 ± 1 | 185 ± 2 | 7 ± 1 | 161 ± 2 | 162 ± 2 | 161 ± 2 | 0 ± 0 |
| 70 | 18.1 ± 7.4 | 260 ± 1 | 283 ± 3 | 349 ± 3 | 94 ± 3 | 177 ± 1 | 180 ± 3 | 219 ± 4 | 41 ± 5 | 157 ± 1 | 162 ± 2 | 186 ± 1 | 25 ± 3 |
| 112 | 18.2 ± 0.9 | 268 ± 4 | 296 ± 3 | 418 ± 5 | 163 ± 5 | 176 ± 2 | 204 ± 3 | 235 ± 4 | 57 ± 4 | 160 ± 2 | 181 ± 3 | 207 ± 3 | 46 ± 2 |
| 140 | 19.0 ± 0.6 | 272 ± 5 | 326 ± 3 | 485 ± 4 | 230 ± 7 | 188 ± 1 | 210 ± 4 | 268 ± 3 | 91 ± 3 | 164 ± 2 | 193 ± 3 | 245 ± 3 | 84 ± 4 |
| 168 | 18.2 ± 0.8 | 275 ± 1 | 335 ± 2 | 512 ± 2 | 257 ± 2 | 184 ± 3 | 224 ± 6 | 275 ± 3 | 98 ± 3 | 164 ± 5 | 212 ± 3 | 253 ± 7 | 92 ± 9 |
| 200 | 17.2 ± 0.8 | 263 ± 2 | 306 ± 7 | 501 ± 4 | 246 ± 5 | 186 ± 1 | 217 ± 7 | 309 ± 7 | 131 ± 8 | 159 ± 2 | 207 ± 8 | 271 ± 9 | 110 ± 9 |
| (R = 0.97 *) | (R = 0.98 *) | (R = 0.98 *) | |||||||||||
| Male | |||||||||||||
| 0 | 22.1 ± 0.5 | 157 ± 3 | 160 ± 3 | 175 ± 4 | 18 ± 5 | 103 ± 5 | 109 ± 7 | 115 ± 11 | 12 ± 6 | 66 ± 3 | 72 ± 5 | 79 ± 5 | 13 ± 3 |
| 70 | 22.9 ± 1.3 | 140 ± 5 | 176 ± 6 | 178 ± 2 | 21 ± 4 | 80 ± 2 | 97 ± 4 | 103 ± 4 | 0 ± 0 | 67 ± 7 | 88 ± 3 | 86 ± 2 | 20 ± 5 |
| 112 | 24.3 ± 1.2 | 160 ± 5 | 171 ± 8 | 182 ± 3 | 25 ± 2 | 83 ± 4 | 97 ± 4 | 121 ± 4 | 18 ± 6 | 73 ± 7 | 89 ± 5 | 89 ± 4 | 23± 5 |
| 140 | 23.1 ± 0.7 | 163 ± 4 | 187 ± 1 | 202 ± 4 | 45 ± 3 | 95 ± 2 | 105 ± 2 | 126 ± 3 | 23 ± 5 | 80 ± 4 | 102 ± 1 | 112 ± 1 | 46 ± 2 |
| 168 | 22.3 ± 1.3 | 158 ± 2 | 216 ± 3 | 294 ± 4 | 137 ± 5 | 101 ± 5 | 121 ± 5 | 161 ± 3 | 58 ± 4 | 66 ± 3 | 78 ± 5 | 154 ± 10 | 88 ± 7 |
| 200 | 21.0 ± 1.0 | 166 ± 1 | 294 ± 4 | 326 ± 2 | 169 ± 3 | 96 ± 4 | 175 ± 3 | 207 ± 2 | 104 ± 7 | 86 ± 1 | 114 ± 1 | 175 ± 2 | 109 ± 3 |
| (R = 0.82 *) | (R = 0.79 *) | (R = 0.87 *) | |||||||||||
| Treatments | Mice Weight | Reflectance and Erythema Measurements of Mice Skin | EIP | |||
|---|---|---|---|---|---|---|
| (g) | t (0 h) | t (24 h) | t (48 h) | EI | ||
| Female mice | ||||||
| Untreated (negative control) | 18.3 ± 1.2 | 255 ± 3 | 267 ± 2 | 270 ± 2 | 15 ± 3 | - |
| 25% Glycerin (Gly) | 15.6 ± 0.3 | 262 ± 2 | 262 ± 2 | 266 ± 2 | 13 ± 3 | - |
| UVB radiation (200 mJ/cm2) | 18.8 ± 1.2 | 267 ± 2 | 306 ± 7 | 515 ± 3 | 260 ± 3 | - |
| Gly + UVB radiation (200 mJ/cm2) | 17.6 ± 0.4 | 252 ± 2 | 301 ± 2 | 489 ± 6 | 234 ± 7 | - |
| Male mice | ||||||
| Untreated (negative control) | 22.9 ± 1.2 | 140 ± 5 | 160 ± 3 | 175 ± 4 | 17 ± 5 | - |
| 25% Glycerin (Gly) | 20.0 ± 1.4 | 164 ± 2 | 169 ± 2 | 167 ± 2 | 1 ± 0 | - |
| UVB radiation (200 mJ/cm2) | 20.1 ± 2.4 | 166 ± 1 | 266 ± 5 | 326 ± 4 | 168 ± 4 | - |
| Gly + UVB radiation (200 mJ/cm2) | 24.5 ± 0.1 | 171 ± 2 | 274 ± 2 | 337 ± 3 | 166 ± 3 | - |
| Apigenin (evaluated in female mice) | ||||||
| Gly + apigenin (48.6 µg/cm2) | 19.7 ± 0.9 | 264 ± 2 | 265 ± 1 | 266 ± 1 | 11 ± 4 | 95.3 |
| Gly + apigenin + 200 mJ/cm2 | 17.6 ± 0.9 | 265 ± 2 | 302 ± 4 | 318 ± 3 | 63 ± 4 * | 73.1 |
| Gly + apigenin + 400 mJ/cm2 | 20.5 ± 0.4 | 265 ± 2 | 320 ± 2 | 316 ± 2 | 61 ± 2 * | 73.9 |
| Gly + apigenin + 600 mJ/cm2 | 18.2 ± 0.7 | 263 ± 1 | 414 ± 5 | 510 ± 2 | 234 ± 2 n.s. | 0.0 |
| Caffeic acid (evaluated in male mice) | ||||||
| Gly + caffeic acid (80.7 μg/cm2) | 22.8 ± 1.4 | 161 ± 1 | 165 ± 1 | 167 ± 2 | 1 ± 1 | 99.4 |
| Gly + caffeic acid + 200 mJ/cm2 | 22.1 ± 0.4 | 155 ± 1 | 191 ± 3 | 219 ± 3 | 47 ± 5 * | 71.7 |
| Gly + caffeic acid + 600 mJ/cm2 | 23.8 ± 0.8 | 161 ± 2 | 209 ± 5 | 220 ± 1 | 49 ± 2 * | 70.5 |
| Gly + caffeic acid + 800 mJ/cm2 | 22.6 ± 0.6 | 161 ± 2 | 208 ± 1 | 221 ± 2 | 50 ± 2 * | 69.9 |
| Gly + caffeic acid + 1000 mJ/cm2 | 22.1 ± 1.0 | 160 ± 2 | 224 ± 2 | 284 ± 2 | 113 ± 1 n.s. | 0.0 |
| EGCG (evaluated in male mice) | ||||||
| Gly + EGCG (198 µg/cm2) | 21.1 ± 0.5 | 163 ± 1 | 167 ± 2 | 162 ± 3 | 1 ± 1 | 99.4 |
| Gly + EGCG + 200 mJ/cm2 | 22.9 ± 0.6 | 167 ± 2 | 184 ± 2 | 204 ± 2 | 32 ± 2 * | 63.8 |
| Gly + EGCG + 400 mJ/cm2 | 22.8 ± 0.5 | 158 ± 2 | 219 ± 4 | 268 ± 3 | 97 ± 5 * | 0.0 |
| Gly + EGCG + 600 mJ/cm2 | 21.3 ± 0.3 | 164 ± 2 | 258 ± 4 | 336 ± 3 | 165 ± 5 n.s. | 0.0 |
| Kaempferol (evaluated in female mice) | ||||||
| Gly + kaempferol (100 μg/cm2) | 19.2 ± 0.1 | 264 ± 2 | 268 ± 3 | 290 ± 3 | 35 ± 3 | 85.0 |
| Gly + kaempferol + 200 mJ/cm2 | 18.9 ± 0.1 | 269 ± 1 | 287 ± 4 | 309 ± 1 | 54 ± 4 * | 76.9 |
| Gly + kaempferol + 400 mJ/cm2 | 17.5 ± 0.2 | 260 ± 2 | 300 ± 3 | 319 ± 3 | 64 ± 5 * | 72.6 |
| Gly + kaempferol + 800 mJ/cm2 | 22.7 ± 2.8 | 267 ± 2 | 345 ± 7 | 360 ± 4 | 105 ± 5 * | 55.1 |
| Gly + kaempferol + 1000 mJ/cm2 | 17.6 ± 0.4 | 252 ± 2 | 301 ± 2 | 489 ± 6 | 234 ± 7 n.s. | 0.0 |
| Pinocembrin (evaluated in male mice) | ||||||
| Gly + pinocembrin (24.5 µg/cm2) | 18.6 ± 0.2 | 168 ± 3 | 163 ± 1 | 165 ± 2 | 3 ± 1 | 98.2 |
| Gly + pinocembrin + 200 mJ/cm2 | 23.8 ± 0.3 | 165 ± 1 | 183 ± 3 | 185 ± 3 | 14 ± 4 * | 91.6 |
| Gly + pinocembrin + 400 mJ/cm2 | 23.3 ± 0.9 | 163 ± 2 | 209 ± 6 | 219 ± 4 | 47 ± 6 * | 66.4 |
| Gly + pinocembrin + 800 mJ/cm2 | 20.8 ± 1.3 | 161 ± 3 | 271 ± 1 | 302 ± 3 | 140 ± 3 n.s. | 0.0 |
| Titanium dioxide (evaluated in female mice) | ||||||
| Gly + titanium dioxide (500 µg/cm2) | 16.9 ± 1.0 | 259 ± 1 | 259 ± 1 | 261 ± 2 | 7 ± 4 | - |
| Gly + titanium dioxide + 200 mJ/cm2 | 17.4 ± 0.4 | 256 ± 1 | 309 ± 3 | 320 ± 2 | 65 ± 4 * | 72.2 |
| Gly + titanium dioxide + 600 mJ/cm2 | 21.2 ± 3.2 | 260 ± 2 | 313 ± 3 | 318 ± 2 | 63 ± 3 * | 73.1 |
| Gly + titanium dioxide + 800 mJ/cm2 | 17.4 ± 3.6 | 257 ± 2 | 326 ± 4 | 445 ± 2 | 190 ± 4 * | 18.8 |
| Gly + titanium dioxide + 1000 mJ/cm2 | 21.6 ± 1.7 | 261 ± 2 | 328 ± 3 | 503 ± 3 | 248 ± 6 n.s. | 0.0 |
| Zinc oxide (evaluated in female mice) | ||||||
| Gly + zinc oxide (500 µg/cm2) | 19.3 ± 0.1 | 260 ± 2 | 258 ± 1 | 259 ± 2 | 6 ± 3 | 97.4 |
| Gly + zinc oxide + 200 mJ/cm2 | 19.0 ± 0.3 | 258 ± 2 | 296 ± 2 | 302 ± 2 | 47 ± 2 * | 79.9 |
| Gly + zinc oxide + 600 mJ/cm2 | 18.8 ± 1.3 | 258 ± 2 | 300 ± 3 | 315 ± 3 | 60 ± 5 * | 74.3 |
| Gly + zinc oxide + 800 mJ/cm2 | 18.1 ± 0.5 | 255 ± 1 | 326 ± 4 | 420 ± 4 | 165 ± 3 * | 29.5 |
| Gly + zinc oxide + 1000 mJ/cm2 | 17.8 ± 0.5 | 256 ± 2 | 336 ± 3 | 469 ± 4 | 260 ± 2 n.s. | 0.0 |
| Tested Samples (Mass) † | SPFin vitro * | MEDu | MEDp | EPE | EPEC | Expected SPF Values for Human Phototypes | |||
|---|---|---|---|---|---|---|---|---|---|
| (mJ/cm2) | (mJ/cm2) | Type I | Type II | Type III | Type IV | ||||
| Glycerin 25% (solvent) | – | 39–80 | 39–80 | 1.0 ± 0.0 | 1.0 ± 0.0 | - | - | - | - |
| Apigenin (48.6 µg) | 11 ± 0 | 39 | 400 | 15.4 ± 0.0 | 19.9 ± 0.0 | 11.4 ± 0.0 | 7.1 ± 0.0 | 5.7 ± 0.0 | 4.8 ± 0.0 |
| Caffeic acid (80.7 µg) | 36 ± 1 | 80 | 800 | 10.0 ± 0.0 | 13.4 ± 0.0 | 22.8 ± 0.0 | 14.3 ± 0.0 | 5.7 ± 0.0 | 4.8 ± 0.0 |
| EGCG (198 µg) | 19 ± 0 | 80 | 200 | 2.5 ± 0.0 | 3.4 ± 0.0 | 5.7 ± 0.0 | 3.6 ± 0.0 | 2.8 ± 0.0 | 2.4 ± 0.0 |
| Kaempferol (100 µg) | 13 ± 0 | 39 | 800 | 20.5 ± 0.0 | 23.4 ± 0.0 | 11.4 ± 0.0 | 7.1 ± 0.0 | 5.7 ± 0.0 | 4.8 ± 0.0 |
| Pinocembrin (24.5 µg) | 9 ± 0 | 80 | 400 | 5.0 ± 0.0 | 7.6 ± 0.0 | 11.4 ± 0.0 | 7.1 ± 0.0 | 5.7 ± 0.0 | 4.8 ± 0.0 |
| Titanium dioxide (500 µg) ‡ | 40 ± 0 | 39 | 600 | 15.4 ± 0.0 | 20.1 ± 0.0 | 17.1 ± 0.0 | 10.7 ± 0.0 | 8.6 ± 0.0 | 7.1 ± 0.0 |
| Zinc oxide (500 µg) ‡ | 40 ± 0 | 39 | 600 | 15.4 ± 0.0 | 20.1 ± 0.0 | 17.1 ± 0.0 | 10.7 ± 0.0 | 8.6 ± 0.0 | 7.1 ± 0.0 |
| R1 = 0.56 (p ˂ 0.14) | R1 = 0.55 (p ˂ 0.15) | R1 = 0.75 (p ˂ 0.03) | R1 = 0.75 (p ˂ 0.03) | ||||||
| R2 = 0.63 (p ˂ 0.09) | R2 = 0.62 (p ˂ 0.10) | R2 = 0.81 (p ˂ 0.01) | R2 = 0.81 (p ˂ 0.01) | ||||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Villamizar Mantilla, D.A.; Nuñez, L.A.; Stashenko, E.E.; Vinardell, M.P.; Fuentes, J.L. Erythema Protection Efficacy of Plant-Derivative Compounds in Mice Based on Narrow-Band Reflectance Spectroscopy Data. Life 2026, 16, 176. https://doi.org/10.3390/life16010176
Villamizar Mantilla DA, Nuñez LA, Stashenko EE, Vinardell MP, Fuentes JL. Erythema Protection Efficacy of Plant-Derivative Compounds in Mice Based on Narrow-Band Reflectance Spectroscopy Data. Life. 2026; 16(1):176. https://doi.org/10.3390/life16010176
Chicago/Turabian StyleVillamizar Mantilla, Diego Armando, Luis Alberto Nuñez, Elena E. Stashenko, María Pilar Vinardell, and Jorge Luis Fuentes. 2026. "Erythema Protection Efficacy of Plant-Derivative Compounds in Mice Based on Narrow-Band Reflectance Spectroscopy Data" Life 16, no. 1: 176. https://doi.org/10.3390/life16010176
APA StyleVillamizar Mantilla, D. A., Nuñez, L. A., Stashenko, E. E., Vinardell, M. P., & Fuentes, J. L. (2026). Erythema Protection Efficacy of Plant-Derivative Compounds in Mice Based on Narrow-Band Reflectance Spectroscopy Data. Life, 16(1), 176. https://doi.org/10.3390/life16010176

